Biomarkers in chemoradiotherapy of cervical cancer : Focus on EGFR and DCE-MR imaging
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10814]
Abstract
No abstract.List of papers
Paper I: Halle C, Lando M, Sundfør K, Kristensen GB, Holm R, Lyng H. Phosphorylation of EGFR measured with in situ proximity ligation assay: Relationship to EGFR protein level and gene dosage in cervical cancer. Radiother Oncol. 2011, 101(1):152-7. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1016/j.radonc.2011.05.052 |
Paper II: Halle C, Lando M, Svendsrud DH, Clancy T, Holden M, Sundfør K, Kristensen GB, Holm R, Lyng H. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph nodenegative cervical cancer. Clinical Cancer Research, 2011, 17(16):5501-12. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1158/1078-0432.CCR-11-0297 |
Paper III: Halle C, Andersen E, Lando M, Hasvold G, Holden M, Syljuåsen R, Sundfør K, Kristensen G, Holm R, Malinen E, Lyng H. Dynamic contrast enhanced - MR imaging portrays hypoxia induced gene expression in chemoradioresistant cervical cancer Manuscript., published as: Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, Syljuåsen RG, Sundfør K, Kristensen GB, Holm R, Malinen E, Lyng H. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1158/0008-5472.CAN-12-1085 |